- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/675 - Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
Patent holdings for IPC class A61K 31/675
Total number of patents in this class: 4834
10-year publication summary
|
307
|
323
|
352
|
329
|
306
|
430
|
434
|
412
|
416
|
403
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2094 |
128 |
| Antecip Bioventures II LLC | 347 |
101 |
| Iovance Biotherapeutics, Inc. | 346 |
69 |
| Immunomedics, Inc. | 260 |
44 |
| Merck Sharp & Dohme LLC | 3737 |
44 |
| The Regents of the University of California | 20289 |
40 |
| The Johns Hopkins University | 5751 |
38 |
| Novartis AG | 10623 |
37 |
| Bristol-myers Squibb Company | 4820 |
36 |
| Rigel Pharmaceuticals, Inc. | 532 |
35 |
| Psilo Scientific Ltd. | 54 |
35 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2911 |
31 |
| Compass Pathfinder Limited | 110 |
25 |
| Achillion Pharmaceuticals, Inc. | 164 |
23 |
| Cipla Limited | 468 |
23 |
| Centre National de La Recherche Scientifique | 10693 |
22 |
| Turtle Bear Holdings, LLC | 88 |
21 |
| Allergan, Inc. | 2314 |
19 |
| Hoffmann-La Roche Inc. | 3533 |
18 |
| Pharmacyclics LLC | 243 |
18 |
| Other owners | 4027 |